MEDI-522
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for MEDI-522, covering 2007-11-27 to 2014-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 1, Phase 2]